+
Site Tour
SURGICAL
VALVE SOLUTIONS
EPIC™ PLUS MITRAL AND AORTIC STENTED TISSUE VALVES

 

The latest generation of the Epic™ Platform continues the Epic product family’s history of excellence. The future-forward design of the Epic Plus mitral and aortic valves gives you and your patients more choices when it comes to preserving long-term treatment paths.

SURGICAL VALVE SOLUTIONS
DURABILITY THAT WITHSTANDS THE LONG-TERM TEST OF TIME

10 YEARS

93.8%*
Freedom from SVD,
All patient ages (Epic™ Mitral Valve)1

96.3%*
Freedom from SVD,
All patient ages (Epic™ Aortic Valve)2

SVD: structural valve deterioration.
*From stand-alone aortic or mitral valve replacements.
 

THE EPIC PLATFORM HAS DEMONSTRATED EXCELLENT DURABILITY IN YOUNGER PATIENTS

The Epic Mitral valve experience from Rennes shows excellent performance in younger patients, with a 10-year freedom from SVD of 87.7% for the age ≤ 59 subgroup.3

87.7%

EPIC MITRAL VALVE FREEDOM FROM SVD, AT 10 YEARS3

EPIC SUPRA VALVE DELIVERS EXCEPTIONAL DURABILITY AND PERFORMANCE

  • Optimal leaflet design minimizes regurgitation
  • Pericardial shield reduces abrasion by creating tissue-to-tissue interface
  • Epic™ valve 10-year durability data show outstanding aortic freedom from SVD2
     

96.3%

EPIC AORTIC VALVE FREEDOM FROM SVD, AT 10 YEARS2

 

STRONG IN VIVO HEMODYNAMICS
 

*NOTE: For references 2–5, data not from head-to-head studies. Data differences depicted between these trials may not be directly comparable, statistically significant, or clinically meaningful due to differences in trial protocols, endpoints, and/or patient populations. Data provided for informational purposes only.
**Pressure gradients approximated through Epic™ Aortic summary of safety and effectiveness data (SSED) matched with stent size equivalencies for the Epic™ Supra. Per Abbott Internal engineering specifications, a 19 mm Epic™ Supra has the same stent size as a 21 mm Epic™ Aortic and this relationship continues across all Epic™ Supra valve sizes.
Indicates a third-party trademark, which is property of its respective owner.

BRINGING YOU...

Clinical Case clubs | Educational tools | Hot topics
Expert opinions | Live & online discussions

 

TV

References
  1. Lehmann S, Jawad K, Meyer A, et al. Long-term follow-up after porcine xenograft mitral valve replacement. Presented at: 2017 American Association For Thoracic Surgery Mitral Conclave. April 27-28, 2017; New York, NY, USA.
  2. Lehmann, S, Merk DR, Etz CD, et al. Porcine xenograft for aortic, mitral and double valve replacement: long-term results of 2544 consecutive patients. Eur J Cardiothorac Surg. 2016;49:1150-1156.
  3. Anselmi A, Aymami M, Tomasi J et al. Durability of mitral valve replacement with a 3rd generation bioprosthesis. Ann Thorac Surg. 2021. doi: doi.org/10.1016/j.athoracsur.2021.03.097.
  4. Biocor Instructions for Use.
  5. Maitland A, Hirsch GA, and Pascoe EA. Hemodynamic performance of the St. Jude Medical Epic Supra Aortic Stented Valve. J Heart Valve Dis, 2011; 20:327-331.

© Abbott 2024. All rights reserved. 9-EH-5-15003-01 03-2024

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline